|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
1/18/2011 8:10:51 AM
Orange County Business Journal -- Israeli drug maker Teva Pharmaceutical Industries Ltd. said Monday it is cutting 200 jobs at its Irvine operation.
The Israeli drug maker said 195 of those jobs would be cut as of Feb. 6, according to a report in the Orange County Register.
Teva spokeswoman Denise Bradley said that the jobs that were being cut were production jobs and support staff in Irvine.
She said that the plant, in the Irvine Spectrum, had been under a voluntary manufacturing and distribution hold since last April.
Teva got its Irvine facility through its 2003 purchase of generic drug maker Sicor Inc. for $3.4 billion.
Last year, Teva laid off 70 workers in Irvine after it stopped producing propofol, a sedative that gained notoriety in the death of Michael Jackson.\
Teva, whose version of propofol wasn’t involved in the Jackson case, stopped making that drug because it was hard to make and it gained little or no profit from it.
The drug maker had other issues with propofol, including a 2009 production stoppage and recall after high levels of toxins were found in vials of the drug made in Irvine.
|
|
|
|
|
|
|
|
|
|
|